A Study to Determine Optimal Absorption of Single Dose Omega-3

Inclusion criteria

• Male and females over 19 years and otherwise healthy
• Healthy BMI >18.0 and <30.0
• Able to provide informed consent
• Agree to arrive fasted on the day of the trial
• Agree to participate in all arms of the study

Exclusion criteria

• Unstable or serious illness [e.g. kidney, liver (including NAFLD), GIT, heart conditions, diabetes, thyroid gland function malignancy]*
• Any treatment that included radiation or chemotherapy within the previous 2 years
• Receiving/prescribed coumandin (Warfarin), heparin, daltaparin, enoxaparin or other anticoagulation therapy.
• Regular use of supplements containing the investigational material (e.g. Omega-3 fatty acids), in the last 3 months, regular consumption of foods containing the investigational material (e.g. fish for omega-3) #
• Active smokers, nicotine, alcohol, drug abuse
• Chronic past and/or current alcohol use (>14 alcoholic drinks week)
• Allergic to any of the ingredients (i.e., fish oil)
• Pregnant or lactating women
• Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion

• An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.

• Regular use or consumption is considered if participants are consuming omega containing supplements or foods on 3 or more days per week.